Literature DB >> 26629202

Association of Adiponectin gene polymorphisms and nonalcoholic fatty liver disease.

Hong-Jue Li1, Chang-Ping Li2, Chao Zhang2, Xiao-Lin Zhong2, Lei Shi2.   

Abstract

OBJECTIVE: To investigate the correlation between Adiponectin gene polymorphisms and the genetic susceptibility of nonalcoholic fatty liver disease (NAFLD).
METHODS: 357 NAFLD patients from January 2005 to December 2013 and 357 cases of healthy controls among the Han population were collected; polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used to detect three tagSNPs (Rs2241767, rsl501299 and rs3774261) of Adiponectin. Risk factors were analyzed by multivariate logistic regression and haplotype analysis was performed using SHEsis software.
RESULTS: Rs2241767, rsl501299 and rs3774261 polymorphisms were associated with the risk of NAFLD. Haplotype analysis showed that, A-T-A haplotype was a protective factor of NAFLD (OR: 0.154, 95% CI: 0.011-0.576, P = 0.004) and G-G-A (OR: 4.012, 95% CI: 2.118-10.324, P < 0.001) and G-T-G (OR: 5.219, 95% CI: 2.751-12.651, P < 0.001) haplotype was risk factors of NAFLD.
CONCLUSION: There was an association between Adiponectin gene polymorphisms and the genetic susceptibility of NAFLD.

Entities:  

Keywords:  Adiponectin; NAFLD; gene polymorphism

Year:  2015        PMID: 26629202      PMCID: PMC4659090     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

Review 1.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.

Authors:  Maryann Maximos; Fernando Bril; Paola Portillo Sanchez; Romina Lomonaco; Beverly Orsak; Diane Biernacki; Amitabh Suman; Michelle Weber; Kenneth Cusi
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

Review 3.  Adiponectin serum level in chronic hepatitis C infection and therapeutic profile.

Authors:  Valentina Peta; Carlo Torti; Natasa Milic; Alfredo Focà; Ludovico Abenavoli
Journal:  World J Hepatol       Date:  2015-01-27

Review 4.  Nonalcoholic Fatty liver disease and psoriasis: what a dermatologist needs to know.

Authors:  Ronald Prussick; Lisa Prussick; Dillon Nussbaum
Journal:  J Clin Aesthet Dermatol       Date:  2015-03

Review 5.  Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.

Authors:  Mazen Noureddin; Mary E Rinella
Journal:  Clin Liver Dis       Date:  2015-03-12       Impact factor: 6.126

Review 6.  Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.

Authors:  Yu-Yuan Li
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

7.  AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression.

Authors:  Bai-Fang Wang; Ying Wang; Ran Ao; Jing Tong; Bing-Yuan Wang
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

Review 8.  Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.

Authors:  Mustafa Koplay; Mesut Sivri; Hasan Erdogan; Alaaddin Nayman
Journal:  World J Hepatol       Date:  2015-04-18

9.  Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population.

Authors:  Z L Wang; B Xia; U Shrestha; L Jiang; C W Ma; Q Chen; H Chen; Z G Hu
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

10.  Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease.

Authors:  Mohammad Hashemi; Hamideh Hanafi Bojd; Ebrahim Eskandari Nasab; Ali Bahari; Noor Allah Hashemzehi; Sara Shafieipour; Behzad Narouie; Mohsen Taheri; Saeid Ghavami
Journal:  Hepat Mon       Date:  2013-05-21       Impact factor: 0.660

View more
  6 in total

1.  Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population.

Authors:  Shui-Xian Du; Lin-Lin Lu; Yang Liu; Quan-Jiang Dong; Shi-Ying Xuan; Yong-Ning Xin
Journal:  Hepat Mon       Date:  2016-06-26       Impact factor: 0.660

2.  Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty Liver Disease Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Jiaxing Liu; Jicheng Xing; Bing Wang; Changyong Wei; Ruining Yang; Yuerong Zhu; Hong Qiu
Journal:  Med Sci Monit       Date:  2019-02-08

3.  Association between ADIPOQ G276T and C11377G polymorphisms and the risk of non-alcoholic fatty liver disease: An updated meta-analysis.

Authors:  Mengwei Liu; Shan Liu; Mengke Shang; Xiuping Liu; Yue Wang; Qian Li; Michael Mambiya; Luping Yang; Qian Zhang; Kaili Zhang; Fangfang Nie; Fanxin Zeng; Wanyang Liu
Journal:  Mol Genet Genomic Med       Date:  2019-03-05       Impact factor: 2.183

4.  Association and functional study between ADIPOQ and metabolic syndrome in elderly Chinese Han population.

Authors:  Qiao Wang; Decheng Ren; Yan Bi; Ruixue Yuan; Dong Li; Jianying Wang; Ruirui Wang; Lei Zhang; Guang He; Baocheng Liu
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

5.  Correlation of Adiponectin Gene Polymorphisms rs266729 and rs3774261 With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Yong-Tian Zheng; Tian-Mei Xiao; Chan-Xian Wu; Jin-Yan Cheng; Le-Yu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-23       Impact factor: 5.555

6.  Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.

Authors:  Christian S Alvarez; Andrea A Florio; Julia Butt; Alvaro Rivera-Andrade; María F Kroker-Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D Freedman; Barry I Graubard; Mariana Lazo; Eliseo Guallar; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  Helicobacter       Date:  2020-10-02       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.